Following these proceedings, Goldman initiated its Nutrien Ltd [NTR] rating to a Sell in a research note published on March 13, 2025; the price target was $53. A number of analysts have revised their coverage, including Barclays’s analysts, who decreased its forecast for the stock in late January from “an Overweight” to “an Equal weight”. Piper Sandler also remained covering NTR and has increased its forecast on January 13, 2025 with a “an Overweight” recommendation from previously “an Underweight” rating. JP Morgan revised its rating on January 13, 2025. It rated NTR as “a Neutral” which previously was an “an Underweight”.
Price Performance Review of NTR
On Monday, Nutrien Ltd [NYSE:NTR] saw its stock jump 1.02% to $56.20. Nutrien Ltd shares have risen nearly 25.59% since the year began. Nevertheless, the stocks have risen 1.39% over the past one year. While a 52-week high of $60.87 was reached on 05/01/25, a 52-week low of $43.69 was recorded on 01/02/25. SMA at 50 days reached $52.09, while 200 days put it at $49.39.
Levels Of Support And Resistance For NTR Stock
The 24-hour chart illustrates a support level at 55.17, which if violated will result in even more drops to 54.13. On the upside, there is a resistance level at 56.73. A further resistance level may holdings at 57.25. The Relative Strength Index (RSI) on the 14-day chart is 61.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 22.95%. Stochastics %K at 64.77% indicates the stock is a holding.
